Watch for Finerenone, a New Med for Diabetic Kidney Disease
November 2021
Finerenone (Kerendia) will be a new med for patients with chronic kidney disease (CKD) due to type 2 diabetes.
Finerenone is thought to limit inflammation and scarring in the kidneys and heart...which may slow kidney disease progression and reduce risk of cardiovascular events (heart attack, etc).
But anticipate that it will be a "niche" med.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote